Cited by 888Lipid metabolism and disordersDiabetes, Cardiovascular Risks, and LipoproteinsLipoproteins and Cardiovascular Health

The DOI matches its Crossref record; 183 of the 183 references it cites were found in a registry or an index.

Diabetic dyslipidaemia: from basic research to clinical practice*

Open access

Taskinen, M.-R.·2003·Diabetologia

DOI 10.1007/s00125-003-1111-y

Open this paper in CoChat — free account Open PDF

Abstract

The recognition that the increase of plasma triglyceride rich lipoproteins (TRLs) is associated with multiple alterations of other lipoproteins species that are potentially atherogenic has expanded the picture of diabetic dyslipidaemia. The discovery of heterogeneity within major lipoprotein classes VLDL, LDL and HDL opened new avenues to reveal the specific pertubations of diabetic dyslipidaemia. The increase of large VLDL 1 particles in Type 2 diabetes initiates a sequence of events that generates atherogenic remnants, small dense LDL and small dense HDL particles. Together these components comprise the atherogenic lipid triad. Notably the malignant nature of diabetic dyslipidaemia is not completely shown by the lipid measures used in clinical practice. The key question is what are the mechanisms behind the increase of VLDL 1 particles in diabetic dyslipidaemia? Despite the advances of recent years, our understanding of VLDL assembly and secretion is still surprisingly incomplete. To date it is still unclear how the liver is able to regulate the amount of triglycerides incorporated into VLDL particles to produce either VLDL 1 or VLDL 2 particles. The current evidence suggests that the machinery driving VLDL assembly in the liver includes (i) low insulin signalling via PI-3 kinase pathway that enhances lipid accumulation into "nascent " VLDL particles (ii) up-regulation of SREBP-1C that stimulates de novo lipogenesis and (iii) excess availability of "polar molecules" in hepatocytes that stabilizes apo B 100. Recent data suggest that all these steps could be fundamentally altered in Type 2 diabetes explaining the overproduction of VLDL apo B as well as the ability of insulin to suppress VLDL 1 apo B production in Type 2 diabetes. Recent discoveries have established the transcription factors including PPARs, SREBP-1 and LXRs as the key regulators of lipid assembly in the liver. These observations suggest these factors as a new target to tailor more efficient drugs to treat diabetic dyslipidaemia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00125-003-1111-y

Cites

183 of 183 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
(2002) · The Lancet · doi:10.1016/s0140-6736(02)09327-3 · Cited by 6,992
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Self-citation
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)
Turner, R. C., Millns, H., Neil, H. A. W., Stratton, I. M., Manley, S. E., Matthews, D. R., & Holman, R. R. (1998) · BMJ · doi:10.1136/bmj.316.7134.823 · Cited by 2,014

Show all 183 references

Sorted by citations

Items 501–600 of 885

Obesity and metabolic abnormalities as risks of alcoholic fatty liver in men: NAGALA study
Yoshimura, Y., Hamaguchi, M., Hashimoto, Y., Okamura, T., Nakanishi, N., Obora, A., Kojima, T., & Fukui, M. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-01893-4 · Cited by 10
Potential contribution of haemoconcentration to changes in lipid variables with empagliflozin in patients with type 2 diabetes: A post hoc analysis of pooled data from four phase 3 randomized clinical trials
Lund, S. S., Sattar, N. A., Salsali, A., Neubacher, D., & Ginsberg, H. N. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14534 · Cited by 9
Diabetes: managing dyslipidaemia.
Patel, J. (2008) · PubMed Central · Cited by 10
Geranium oil ameliorates endothelial dysfunction in high fat high sucrose diet induced metabolic complications in rats
Kshirsagar, R. P., Kothamasu, M. V., Patil, M. A., Reddy, G. B., Kumar, B. D., & Diwan, P. V. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.03.029 · Cited by 10
Derangements of intravascular remodeling of lipoproteins in type 2 diabetes mellitus: Consequences for atherosclerosis development
Dallinga‐Thie, G. M., Dullaart, R. P. F., & van Tol, A. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0012-3 · Cited by 10
Effects of Low-density Lipoprotein Cholesterol on Coronary Artery Calcification Progression According to High-density Lipoprotein Cholesterol Levels
Lee, W., Kim, J. H., Park, S. E., Park, C. ‐., Oh, K.-W., Park, S.-W., Rhee, E., & Lee, W. (2017) · Archives of Medical Research · doi:10.1016/j.arcmed.2017.06.005 · Cited by 9
Correlation between glycemic control markers and lipid profile in type 2 diabetes mellitus and impaired glucose tolerance
Biradar, S. B., Desai, A. S., Kashinakunti, S. V., Rangappa, M., Kallaganada, G. S., & Devaranavadagi, B. B. (2018) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20182489 · Cited by 10
Efficacy of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide (P32/98) in fatty Zucker rats with incipient and manifest impaired glucose tolerance
Augstein, P., Berg, S., Heinke, P., Altmann, S., Salzsieder, E., Demuth, H. U., & Freyse, E. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00813.x · Cited by 10
Physiopathologie de la dyslipidémie du syndrome métabolique et du diabète de type 2
Vergès, B. L. (2007) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2007.01.011 · Cited by 10
Dyslipidemia in the metabolic syndrome
Chan, D. C., & Watts, G. F. (2004) · Journal of Drug Evaluation · doi:10.3109/14791130410001728524 · Cited by 10
Effects of fluvastatin slow-release (xl 80 mg) versus simvastatin (20 mg) on the lipid triad in patients with type 2 diabetes
Bevilacqua, M. T., Righini, V., Barrella, M., Vago, T., Chebat, E., & Dominguez, L. J. (2005) · Advances in Therapy · doi:10.1007/bf02849947 · Cited by 10
When HDL Gets Fat …
Brown, R., & Rader, D. J. (2008) · Circulation Research · doi:10.1161/circresaha.108.180638 · Cited by 10
Fat-Free Mass and Skeletal Muscle Mass Gain Are Associated with Diabetes Remission after Laparoscopic Sleeve Gastrectomy in Males but Not in Females
Nguyen, N. T. K., Vo, N.-P., Huang, S., & Wang, W. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19020978 · Cited by 9
Both LDL and HDL particle concentrations associate positively with an increased risk of developing microvascular complications in patients with type 2 diabetes: lost protection by HDL (Zodiac-63)
Bourgonje, A. R., Connelly, M. A., van Goor, H., van Dijk, P. R., & Dullaart, R. P. F. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01909-1 · Cited by 10
Patterns of Lipid Abnormalities in Obesity: A Comparative Analysis in Normoglycemic and Prediabetic Obese Individuals
Alshuweishi, Y., Almufarrih, A. A., Abudawood, A., Alfayez, D. I., Alkhowaiter, A. Y., AlSudais, H., & Almuqrin, A. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14090980 · Cited by 13
Effects of Free Linoleic Acid and Oleic Acid in Sesame Meal Extract as Pancreatic Lipase Inhibitors on Postprandial Triglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Volunteers
Li, X., Yamada, H., Morita, S., Yamashita, Y., Kim, Y.-I., Kometani, T., Narang, N., Furuta, T., & Kim, M. (2023) · Nutrients · doi:10.3390/nu15071748 · Cited by 9
Cardiovascular Disease Risk Factors Profile in Individuals With Diabetes Compared With Non-Diabetic Subjects in North-East of Iran
Niroumand, S., Dadgarmoghaddam, M., Eghbali, B., Abrishami, M., Gholoobi, A., Taghanaki, H. R. B., & Khajedaluee, M. (2016) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.29382 · Cited by 9
Effect of Gender and Body Weight on Postprandial Glucose and Lipid Metabolism in Adults with Type 2 Diabetes
Diaf, M., Khaled, M. B., Houari, H. H., & Belbraoued, S. (2014) · Journal of Nepal Medical Association · doi:10.31729/jnma.2707 · Cited by 9
Hypolipidemic and anti-inflammatory effect of chitosan in experimental induced non -alcoholic fatty liver disease in rats
Abo-Zaid, O. A., Abdel-Hamid, O., & Atwa, S. A. E. (2015) · Benha Veterinary Medical Journal · doi:10.21608/bvmj.2015.32730 · Cited by 9
Relationships of adipocyte-fatty acid binding protein and lipocalin 2 with risk factors and chronic complications in type 2 diabetes and effects of fenofibrate: A fenofibrate Intervention and event lowering in diabetes sub-study
Ong, K. L., Wu, L., Januszewski, A. S., O'Connell, R. L., Xu, A., Rye, K., Ronald, C. W., Li, H., Jenkins, A. J., Jia, W., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108450 · Cited by 9
COVID-19 induces proatherogenic alterations in moderate to severe non-comorbid patients: A single-center observational study
Kimura, L. F., Sant’Anna, M. B., de Andrade, S. A., Ebram, M. C., Lima, C. F. G., Celano, R. M. G., Viégas, R. F. M., & Picolo, G. (2021) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2021.102604 · Cited by 9
Decreased high‐density lipoprotein cholesterol is associated with inflammation and insulin resistance in non‐diabetic haemodialysis patients
Peng, Y., Chiu, Y., CHEN, H., Yang, J., Lai, C., Hsu, S.-P., & Pai, M. (2010) · Nephrology · doi:10.1111/j.1440-1797.2010.01295.x · Cited by 9
Why, when and how should hypertriglyceridemia be treated in the high-risk cardiovascular patient?
Watts, G. F., & Karpe, F. (2011) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.11.61 · Cited by 10
Glycemic Control and Diabetic Dyslipidemia in Adolescents with Type 2 Diabetes
Le, P. T., Huisingh, C., & Huisingh, A. (2013) · Endocrine Practice · doi:10.4158/ep13016.or · Cited by 9
Effect of niacin on preβ-1 high-density lipoprotein levels in diabetes
Pan, J., Shilian, P., Ishida, B. Y., Wu, X., Kane, J. P., Malloy, M. J., & Charles, M. A. (2010) · Metabolism · doi:10.1016/j.metabol.2010.01.029 · Cited by 9
Autophagy Regulates Ferroptosis‐Mediated Diabetic Liver Injury by Modulating the Degradation of ACSL4
Wu, L., Lai, W., Li, L., Yang, S., Li, F., Yang, C., Gong, X., & Wu, L. (2024) · Journal of Diabetes Research · doi:10.1155/jdr/7146054 · Cited by 8
A Comparative Study of Lipid Profile Abnormality between Male and Female Diabetes Patients in Savar Region
Akter, R., Tasnim, N., Akter, M. T., Hossain, M. K., Rahman, M. A., Pinky, K. T. K., Hossain, S., Jobayer, M., Hosain, M. K., Zahan, A. A., et al. (2025) · American Journal of Pure and Applied Biosciences · doi:10.34104/ajpab.024.01970202 · Cited by 8
Association of obesity and LDL subfractions evaluated by body mass index, waist circumference, and diabetes status: the ELSA-Brasil study
Moraes, E. G., Generoso, G., Benseñor, I. M., Santos, R. D., Santos, I. S., Goulart, A. C., Jones, S. R., Kulkarni, K. R., Blaha, M. J., Toth, P. P., et al. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01644-5 · Cited by 8
Lipid profile metabolism, pathophysiology, clinical correlations, and therapeutic strategies in cardiovascular and metabolic diseases
Yameny, A. A. (2025) · Pharaonic Journal of Science · doi:10.71428/pjs.2025.0107 · Cited by 14
High LDL Particle and APOB Concentrations in Patients With Adrenal Cortical Adenomas
Sandooja, R., Saini, J., Kittithaworn, A., Garcia, R. G., Dogra, P., Atkinson, E. J., Yu, K., Fell, V. M., Simha, V., Connelly, M. A., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae392 · Cited by 8
Riesgo elevado de disfunción lipoproteica en la diabetes mellitus tipo 2
Carmena, R. (2008) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(08)73551-9 · Cited by 9
The APOA5−1131 T>C variant enhances the association between RBP4 and hypertriglyceridemia in diabetes
Cabré, A., Lázaro, I., Girona, J., Manzanares, J. M., Marimón, F., Plana, N., Guardiola, M., Heras, M., & Masana, L. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.04.003 · Cited by 8
Reno-protection of G004, a novel anti-diabetic sulfonylurea in db/db mice
Tong, X., Ma, H., Amadi, S. W., Ma, L., & Wu, G. (2015) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-015-1112-7 · Cited by 8
Glucose Intake and Utilization in Pre-Diabetes and Diabetes
Shidfar, F., & Arjomand, G.-N. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-800093-9.00024-7 · Cited by 8
Prevalence and Regulation of Dyslipidemia Among Adults With Type 2 Diabetes From Three Primary Health Care Centers in Riyadh
Saleh, F. B., Alharbi, W. S., Alanazi, G. B., & Aldughaither, A. (2022) · Cureus · doi:10.7759/cureus.27573 · Cited by 8
Correlation of lipid profile among patients with hypothyroidism and type 2 diabetes mellitus
Ghosh, A., Kundu, D., Rahman, F., Zafar, M., Prasad, K., Baruah, H., & Mukhopadhyay, T. (2018) · BLDE University Journal of Health Sciences · doi:10.4103/bjhs.bjhs_36_17 · Cited by 8
Establishment of a HEK293 cell line by CRISPR/Cas9-mediated luciferase knock-in to study transcriptional regulation of the human SREBP1 gene
Li, Z., Zhao, J., Muhammad, N., Wang, D., Mao, Q., & Xia, H. (2018) · Biotechnology Letters · doi:10.1007/s10529-018-2608-2 · Cited by 8
Catechins as antidiabetic compounds of Bridelia ferruginea Benth root bark extract
Bakoma, B., Berke, B., Diallo, A., Eklu‐Gadegbeku, K., Kodjo, A. A., Gbéassor, M., & Nicholas, M. (2018) · Journal of Pharmacognosy and Phytotherapy · doi:10.5897/jpp2018.0528 · Cited by 8
Lipid Profile Abnormalities in Bangladeshi Type 2 Diabetic Patients Attending a Tertiary Care Hospital: A Cross-Sectional Study
Begum, A., & Irfan, S. R. (2019) · Bangladesh Critical Care Journal · doi:10.3329/bccj.v7i1.40767 · Cited by 8
Intra-Abdominal Fat and High Density Lipoprotein Cholesterol Are Associated in a Non-Linear Pattern in Japanese-Americans
Song, S. O., Hwang, Y., Kahn, S. E., Leonetti, D. L., Fujimoto, W. Y., & Boyko, E. J. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0008 · Cited by 8
Contribution of the atherogenic lipoprotein profile to the development of arterial hypertension
Oravec, S., Dukát, A., Gavorník, P., Čaprnda, M., Kucera, M., & Očadlík, I. (2011) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03657562 · Cited by 8
Detection of Free Antielastin Antibodies among Diabetic Children
Nicoloff, G., Blazhev, A., Petrova, C., Christova, P., Jordanova-Laleva, P., Dekov, D., & Dorovski, P. (2005) · Journal of Investigative Medicine · doi:10.2310/6650.2005.00308 · Cited by 8
Determinants of postprandial triglyceride and remnant-like lipoproteins in type 2 diabetes
Tan, K. C. B., Tso, A. W. K., Ma, O. C. K., Pang, R. W. C., Tam, S., & Lam, K. S. L. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.504 · Cited by 8
Extracellular Vesicles From Chylomicron-Treated Endothelial Cells Drive Macrophage Inflammation
Tilp, A., Nasias, D., Carley, A., Park, M. Y., Mooring, A., Tirumalasetty, M. B., Abumrad, N. A., Wang, Y., Miao, Q., Lewandowski, E. D., et al. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.322712 · Cited by 7
Physiopathologie de la dyslipidémie du diabète de type 2 : nouvelles perspectives
Vergès, B. L. (2019) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(19)30043-4 · Cited by 7
Macronutrient intake modulates impact of EcoRI polymorphism of ApoB gene on lipid profile and inflammatory markers in patients with type 2 diabetes
Abaj, F., & Koohdani, F. (2022) · Scientific Reports · doi:10.1038/s41598-022-13330-x · Cited by 8
Non-Fasting Hypertriglyceridemia Burden as a Residual Risk of the Progression of Carotid Artery Stenosis
Miura, Y., Yasuda, R., Toma, N., & Suzuki, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169197 · Cited by 7
Prospective randomized comparative study of the effect of pemafibrate add‐on or double statin dose on small dense low‐density lipoprotein ‐cholesterol in patients with type 2 diabetes and hypertriglyceridemia on statin therapy
Hirano, T., Hayashi, T., Sugita, H., Tamasawa, A., Goto, S., Tomoyasu, M., Yamamoto, T., Ohara, M., Terasaki, M., Kushima, H., et al. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14076 · Cited by 8
Hubungan antara Dislipidemia dengan Diabetes Melitus Tipe 2 di Rumah Sakit Ibnu Sina Makassar
M.Abrar Naufal Hidayatullah, Z. A., Gayatri, S. W., Pramono, S. D., Hidayati, P. H., & Syamsu, R. F. (2022) · FAKUMI MEDICAL JOURNAL Jurnal Mahasiswa Kedokteran · doi:10.33096/fmj.v2i9.122 · Cited by 7
Serum AGE-elastin derived peptides among diabetic children
Nicoloff, G., NIKOLOV, A. G., & Dekov, D. (2005) · Vascular Pharmacology · doi:10.1016/j.vph.2005.03.007 · Cited by 7
Metabolism of chylomicrons in patients with congenital lipoatrophic diabetes: a study with emulsion models of chylomicrons
WAJCHENBERG, B. L., Amâncio, R. F., Santomauro, A. T. M. G., & Maranhão, R. C. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02103.x · Cited by 7
Lipoprotein(a) Is the Best Single Marker in Assessing Unstable Angina Pectoris
Djordjević, V. B., Ćosić, V., Stojanović, I. R., Kundalić, S., Zvezdanović, L., Deljanin-Ilić, M., Vlahović, P., & Popović, L. (2011) · Cardiology Research and Practice · doi:10.4061/2011/175363 · Cited by 7
Treatment of dyslipidemia in patients with type 2 diabetes: Overview and meta-analysis of randomized trials
Tkáč, I. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.09.011 · Cited by 7
Atorvastatin or fenofibrate on post‐prandial lipaemia in type 2 diabetic patients with hyperlipidaemia
Iovine, C., Lilli, S., Gentile, A., Patti, L., di Marino, L., Cipriano, P., Riccardi, G., & Rivellese, A. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01677.x · Cited by 8
Quality of Diabetes Care at Outpatient Clinic, Sultan Qaboos University Hospital
Al-Sinani, S., Al-Mamari, A., Woodhouse, N., Al-Shafie, O., Amar, F., Al‐Shafaee, M., Hassan, M. O., & Bayoumi, R. (2015) · Oman Medical Journal · doi:10.5001/omj.2015.09 · Cited by 7
Dyslipidemia in Obesity
Chan, D. C., Pang, J., & Watts, G. F. (2016) · Springer eBooks · doi:10.1007/978-3-319-11251-0_30 · Cited by 10
Postprandial triglyceride-rich lipoproteins in insulin resistance and Type 2 diabetes
Matikainen, N., & Taskinen, M. (2008) · Future Lipidology · doi:10.2217/17460875.3.5.531 · Cited by 7
Self-citation
Pathogenesis and treatment of diabetic vascular disease – illustrated by two cases
Smith, U., Laakso, M., Eliasson, B., Wesslau, C., Borén, J., Wiklund, O., & Attvall, S. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01712.x · Cited by 7
Cardiovascular Disease in Diabetes
Piché, M., & Poirier, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95793-3 · Cited by 7
Deciphering the NLRP3 inflammasome in diabetic encephalopathy: Molecular insights and emerging therapeutic targets
Zeng, X., Yuan, Y., Li, Y., Hu, Z., & Hu, S. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115304 · Cited by 8
Antihyperglycemic, Antihyperlipidemic, and Antioxidant Effects of Salvia tingitana in Streptozotocin-Induced Diabetic Rats
Eddouks, M., & Azzane, A. (2022) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x22666220806122012 · Cited by 6
Lipoprotein(a) as a Higher Residual Risk for Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus than without
Yu, B., Hu, X., Liu, J., Nie, Z., Bu, C. R. L., Li, G., Zhou, Y., & Dong, H. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s423458 · Cited by 6
Importance of Screening Type-II Diabetics for Thyroid Dysfunction and Dyslipidemia
Yadav, P., Kaushik, G. G., & Sharma, S. (2015) · International Journal of Biochemistry and Biophysics · doi:10.13189/ijbb.2015.030201 · Cited by 6
Lipid Metabolism in Metabolic Syndrome
Borén, J., & Adiels, M. (2013) · Springer eBooks · doi:10.1007/978-3-319-01008-3_8 · Cited by 6
Metabolomic profiling and antidiabetic potential of Rumex vesicarius seed extract in high-fat diet and streptozotocin-induced diabeticrat
Rahman, A., Ibrahim, M., Siddiqui, J. I., Ansari, S. A., & Ahmad, S. (2022) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902022e21032 · Cited by 6
Switching fibrate to statin in type 2 diabetic patients: Consequences on lipid profile
Meas, T., Laloi-Michelin, M., Virally, M., Peynet, J., Giraudeaux, V., Kévorkian, J.-P., & Guillausseau, P.-J. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2008.06.009 · Cited by 6
Effect of Dongchunghacho (Cordyceps militaris) on hyperglycemia and dyslipidemia in type 2 diabetic db/db mice
Choi, H., Kang, M., Jeong, S.-M., Seo, M. J., Kang, B. W., Jeong, Y. K., & Kim, J.-I. (2012) · Food Science and Biotechnology · doi:10.1007/s10068-012-0151-9 · Cited by 6
Interactions between CKD and MetS and the Development of CVD
Aihara, K., Mogi, M., Shibata, R., Bishop‐Bailey, D., & Ma, X. L. (2011) · Cardiology Research and Practice · doi:10.4061/2011/878065 · Cited by 5
Combination lipid therapy in type 2 diabetes mellitus
Vergès, B. L. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.558503 · Cited by 6
TRENDS OF LIPID ABNORMALITIES IN PAKISTANI TYPE-2 DIABETES MELLITUS PATIENTS: A TERTIARY CARE CENTRE DATA
Bhatti, S. M., Dhakam, S. H., & Khan, M. A. (2009) · Pakistan Journal of Medical Sciences · Cited by 6
Synergistic effect of metformin and fenugreek on the lipid profile of type-II diabetic patients
Kaur, M., & Singh, N. P. (2019) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20193135 · Cited by 6
Increased Circulating Levels of Ectodysplasin A in Newly Diagnosed Type 2 Diabetic Patients
Deng, X., Cai, Z., Li, Y., Wu, X., Zhao, L., Li, H., Chen, K., Zhang, P., Wang, C., Zhao, Z., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.737624 · Cited by 6
Decreased GPIHBP1 protein levels in visceral adipose tissue partly underlie the hypertriglyceridemic phenotype in insulin resistance
Surendran, R. P., Udayappan, S. D., Clemente‐Postigo, M., Havik, S. R., Schimmel, A. W. M., Tinahones, F. J., Nieuwdorp, M., & Dallinga‐Thie, G. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205858 · Cited by 6
Treatment of lipid disorders in patients with diabetes
Colhoun, H., & Betteridge, D. (2006) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-006-0024-8 · Cited by 9
Multiple factors and pathways involved in hepatic very low density lipoprotein-apoB100 overproduction in Otsuka Long-Evans Tokushima fatty rats
Qin, B., Anderson, R. A., Kuzuya, T., Kitaura, Y., & Shimomura, Y. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.03.033 · Cited by 6
Divergent in vitro and in vivo lipid peroxidation in the postprandial phase of patients with type I diabetes mellitus
Manuel‐y‐Keenoy, B., de Vos, C., Campenhout, A. V., Vinckx, M., Abrams, P. J., & Campenhout, C. V. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602698 · Cited by 6
Differential lipid profile and hormonal response in type 2 diabetes by exogenous insulin aspart versus the insulin secretagogue repaglinide, at the same glycemic control
Chisalita, S. I., Lindström, T., Jennersjö, P. E. S., Paulsson, J. F., Westermark, G. T., OLSSON, A. G., & Arnqvist, H. J. (2008) · Acta Diabetologica · doi:10.1007/s00592-008-0055-6 · Cited by 5
Management of dyslipidemia in elderly diabetic patients
Verny, C. (2005) · Diabetes & Metabolism · doi:10.1016/s1262-3636(05)73655-7 · Cited by 6
Management of dyslipidaemia in patients with comorbidities: facing the challenge: type 2 diabetes mellitus
Drexel, H., Festa, A., Schmidt, T. A., Rocca, B., Dobrev, D., Agewall, S., Tamargo, J. L., & Kaser, S. (2025) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvaf076 · Cited by 6
Remnant cholesterol predicts the development of type 2 diabetes in patients with nonalcoholic fatty liver disease
Yang, L., Huang, H., Wang, Z., & Xu, C. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01828-z · Cited by 5
Advances in Lipid Testing and Management in Patients with Diabetes Mellitus
Vasudevan, M. M., & Ballantyne, C. M. (2009) · Endocrine Practice · doi:10.4158/ep09190.ra · Cited by 5
Generation of ENU‐Induced Mouse Mutants with Hypocholesterolemia: Novel Tools for Dissecting Plasma Lipoprotein Homeostasis
Aigner, B., Rathkolb, B., Mohr, M., Klempt, M., de Angelis, M. H., & Wolf, E. (2007) · Lipids · doi:10.1007/s11745-007-3075-z · Cited by 5
Investigation of the synergistic effect of glimepiride and rosuvastatin on alloxan-induced diabetic rat
Mondol, D., Islam, M. N., Biswas, S., Jodder, P., Sana, S., Saleh, M. A., & Islam, M. R. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00662-6 · Cited by 5
Nomogram model for the risk of insulin resistance in obese children and adolescents based on anthropomorphology and lipid derived indicators
You-xiang, C., & Lin, Z. (2023) · BMC Public Health · doi:10.1186/s12889-023-15181-1 · Cited by 5
Sex-specific responses in glucose-insulin homeostasis and lipoprotein-lipid components after high-dose supplementation with marine n-3 PUFAs in abdominal obesity: a randomized double-blind crossover study
Laupsa‐Borge, J., Grytten, E., Bohov, P., Bjørndal, B., Strand, E., Skorve, J., Nordrehaug, J. E., Berge, R. K., Rostrup, E., Mellgren, G., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1020678 · Cited by 5
The Relationship Between Remnant Cholesterol and Visceral Adipose Tissue: A National Cross-Sectional Study
Wang, Z., Zhong, S., Wu, M., Shao, X., Gu, T., Xu, M., & Yang, Q.-C. (2024) · Hormone and Metabolic Research · doi:10.1055/a-2357-2579 · Cited by 5
A non-linear association between low-density lipoprotein cholesterol and the risk of diabetic kidney disease in patients with type 2 diabetes in China
Xiang, X., Chen, G., Ma, Y., & Wang, H. (2024) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2024.102840 · Cited by 5
Type 2 diabetes with good glycemic control have improved insulin response and lower non-esterified fatty acid level after a meal challenge
Yahaya, N., Kyi, W. M., Noor, N. M., & Bebakar, W. M. W. (2012) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2012.21001 · Cited by 5
The association between fasting serum insulin, apo-lipoproteins level, and severity of coronary artery involvement in non-diabetic patients
Golshahi, J., Validi, E., & Akbari, M. (2014) · Advanced Biomedical Research · doi:10.4103/2277-9175.140624 · Cited by 5
Gal-geun-dang-gwi-tang improves diabetic vascular complication in apolipoprotein E KO mice fed a western diet
Lee, S. M., Lee, Y. J., Choi, J. H., Kho, M. C., Yoon, J. J., Shin, S. H., Kang, D. G., & Lee, H. S. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-453 · Cited by 5
Dyslipidemia: Pathogenesis and Management
Ganda, O. P. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_28 · Cited by 5
Association of Common Genetic Variants in Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 with Type 2 Diabetes Mellitus in a Chinese Han Population
Li, T., Qiao, H., Tong, H., Zhuang, T.-W., & Wang, T.-T. (2016) · Chinese Medical Journal · doi:10.4103/0366-6999.181969 · Cited by 5
Plasma Lipoprotein Particle Subclasses in Preterm Infants
Scoble, J. A., Smilowitz, J. T., Argov-Argaman, N., German, J. B., & Underwood, M. A. (2017) · American Journal of Perinatology · doi:10.1055/s-0037-1607347 · Cited by 5
Apolipoprotein A-I stimulates secretion of insulin and matrix metalloproteinases by islets of Langerhans
Федорович, У. И., Poteryaeva, O. N., Русских, Г. С., Zubova, A., Boiko, K. Y., & Polyakov, L. M. (2018) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20186402195 · Cited by 5
PPAR-γ agonists, insulin resistance and dyslipidemia: not a simple relationship
Johns, B., & Reaven, G. M. (2010) · Clinical Lipidology · doi:10.2217/clp.10.36 · Cited by 5
HDL functionality in diabetes mellitus: potential importance of glycation
Younis, N. N., & Durrington, P. N. (2012) · Clinical Lipidology · doi:10.2217/clp.12.60 · Cited by 5
Improved Estimation of Human Lipoprotein Kinetics with Mixed Effects Models
Berglund, M., Adiels, M., Taskinen, M., Borén, J., & Wennberg, B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138538 · Cited by 5
Self-citation
Association of Hyperlipidemia and Hyperglycemia With Cognitive Function in Type 2 Diabetes: A Cross-Sectional Analysis
Ansari, T., & Sawane, M. (2024) · Cureus · doi:10.7759/cureus.72227 · Cited by 5
Efficacy and Safety of Atorvastatin 40 mg versus Rosuvastatin 20 mg in Patients with Type 2 Diabetes Mellitus and Previous Acute Coronary Syndrome: A Randomized Clinical Trial
Ebid, A. I. M., Genina, Y. M. F., Al-Jendy, A.-M. A., & El-Sawy, A. M. (2022) · Clinical Diabetology · doi:10.5603/dk.a2022.0021 · Cited by 4
Effect of fixed-dose combination of insulin degludec and liraglutide on apoB-containing lipoprotein subclasses and HDL lipidome in type 2 diabetes
Pappa, E. T., Kostara, C. E., Bairaktari, E. T., Arvaniti, E., & Tsimihodimos, V. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108286 · Cited by 4

Authors: Taskinen, M.-R.
Affiliations: University of Helsinki (FI)
Corresponding author: Taskinen, M.-R.
ORCID: Taskinen, M.-R.
Venue: Diabetologia
Publisher: Springer Science and Business Media LLC
Published: 2003-06-01
Volume: 46
Issue: 6
Pages: 733-749
ISSN: 0012-186X (ISSN-L)
1432-0428
DOI: 10.1007/s00125-003-1111-y
OpenAlex: W2020659754
Cited by: 888
References: 183
Citations by year: 2026: 27 · 2025: 37 · 2024: 32 · 2023: 36 · 2022: 48 · 2021: 41 · 2020: 39 · 2019: 27 · 2018: 32 · 2017: 28 · 2016: 29 · 2015: 47 · 2014: 41 · 2013: 46 · 2012: 42
FWCI: 6.10
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
Locations: Diabetologia (publishedVersion)
PubMed (publishedVersion)
Funders: Helsingin ja Uudenmaan Sairaanhoitopiiri
Academy of Finland
Diabetesliitto
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Keywords: diabetic dyslipidemia, type 2 diabetes, small dense LDL, triglyceride-rich lipoproteins, VLDL assembly, hepatic lipid metabolism, insulin signaling, PI3-kinase, SREBP-1c, de novo lipogenesis, apolipoprotein B-100, peroxisome proliferator-activated receptors, SREBP1, liver X receptor
MeSH terms: Diabetes Mellitus, Diabetes Mellitus, Type 2, Humans, Hyperlipidemias, Lipoproteins, Lipoproteins, VLDL, Diabetes Complications, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Diabetic dyslipidaemia: from basic research to clinical practice*

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks